These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 15101839)

  • 1. Levetiracetam in focal epilepsy and hepatic porphyria: a case report.
    Paul F; Meencke HJ
    Epilepsia; 2004 May; 45(5):559-60. PubMed ID: 15101839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute psychosis associated with levetiracetam.
    Youroukos S; Lazopoulou D; Michelakou D; Karagianni J
    Epileptic Disord; 2003 Jun; 5(2):117-9. PubMed ID: 12875956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Paroxysmal tonic upward gaze deviation triggered by valproic acid within the context of focal epilepsy].
    Cantarin-Extremera V; Gutierrez-Solana LG; Duat-Rodriguez A; Lopez-Marin L; Ruiz-Falco ML; Leon-Gonzalez M; Perez-Villena A
    Rev Neurol; 2011 Sep; 53(5):318-9. PubMed ID: 21796611
    [No Abstract]   [Full Text] [Related]  

  • 4. Hypersomnia in an epilepsy patient treated with levetiracetam.
    Khatami R; Siegel AM; Bassetti CL
    Epilepsia; 2005 Apr; 46(4):588-9. PubMed ID: 15816957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The place of levetiracetam in the treatment of epilepsy.
    Leppik IE
    Epilepsia; 2001; 42 Suppl 4():44-5. PubMed ID: 11564126
    [No Abstract]   [Full Text] [Related]  

  • 6. Psychic disturbances associated with sodium valproate plus levetiracetam.
    Siniscalchi A; Gallelli L; De Fazio S; De Sarro G
    Ann Pharmacother; 2007 Mar; 41(3):527-8. PubMed ID: 17327289
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy and safety of levetiracetam in the treatment of Panayiotopoulos syndrome.
    García C; Rubio G
    Epilepsy Res; 2009 Aug; 85(2-3):318-20. PubMed ID: 19423296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxcarbazepine in focal epilepsy and hepatic porphyria: a case report.
    Gaida-Hommernick B; Rieck K; Runge U
    Epilepsia; 2001 Jun; 42(6):793-5. PubMed ID: 11422339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Status gelasticus associated with levetiracetam as add-on treatment.
    Pustorino G; Spano M; Sgro DL; Di Rosa G; Tricomi G; Bellantone D; Tortorella G
    Epileptic Disord; 2007 Jun; 9(2):186-9. PubMed ID: 17525032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catatonia induced by levetiracetam.
    Chouinard MJ; Nguyen DK; Clément JF; Bruneau MA
    Epilepsy Behav; 2006 Feb; 8(1):303-7. PubMed ID: 16249124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective assessment of levetiracetam pharmacokinetics during dose escalation in 4- to 12-year-old children with partial-onset seizures on concomitant carbamazepine or valproate.
    Fountain NB; Conry JA; Rodríguez-Leyva I; Gutierrez-Moctezuma J; Salas E; Coupez R; Stockis A; Lu ZS
    Epilepsy Res; 2007 Apr; 74(1):60-9. PubMed ID: 17270398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levetiracetam: new preparation. For some patients with refractory partial epilepsy.
    Prescrire Int; 2003 Apr; 12(64):53-4. PubMed ID: 12674114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurocognitive effects of adjunctive levetiracetam in children with partial-onset seizures: a randomized, double-blind, placebo-controlled, noninferiority trial.
    Levisohn PM; Mintz M; Hunter SJ; Yang H; Jones J;
    Epilepsia; 2009 Nov; 50(11):2377-89. PubMed ID: 19702752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levetiracetam in a neonate with malignant migrating partial seizures.
    Hmaimess G; Kadhim H; Nassogne MC; Bonnier C; van Rijckevorsel K
    Pediatr Neurol; 2006 Jan; 34(1):55-9. PubMed ID: 16376281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levetiracetam versus carbamazepine monotherapy for partial epilepsy in children less than 16 years of age.
    Perry S; Holt P; Benatar M
    J Child Neurol; 2008 May; 23(5):515-9. PubMed ID: 18182645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy of keppra in combined therapy in pharmacoresistant adult epilepsy patients].
    Karlov VA; Vlasov PN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(7):38-44. PubMed ID: 16117145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of levetiracetam on the pharmacokinetics of adjunctive antiepileptic drugs: a pooled analysis of data from randomized clinical trials.
    Gidal BE; Baltès E; Otoul C; Perucca E
    Epilepsy Res; 2005; 64(1-2):1-11. PubMed ID: 15823510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of levetiracetam in pharmacoresistant continuous spikes and waves during slow sleep.
    Capovilla G; Beccaria F; Cagdas S; Montagnini A; Segala R; Paganelli D
    Acta Neurol Scand; 2004 Sep; 110(3):144-7. PubMed ID: 15285769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium valproate in epilepsy treatment.
    Brown EG
    Practitioner; 1986 Mar; 230(1413):204. PubMed ID: 3086857
    [No Abstract]   [Full Text] [Related]  

  • 20. A case of levetiracetam-induced thrombocytopenia.
    Oghlakian R; Nock C; Koubeissi M
    Epileptic Disord; 2010 Dec; 12(4):335-7. PubMed ID: 21078583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.